Name of bioresource/bank
DNA and cell bank of the Cricm
Name of Principal Investigator
| Title | Professor |
| First name | Alexis |
| Last name | BRICE |
Address of institution where award is held
| Institution | Cricm |
| Street Address | |
| City | PARIS |
| Postcode | 75013 |
Country
France
Website
http://www.cricm.upmc.fr/
Contact email (e.g. manager or coordinator)
Funding source
*French public research fundings from:
-research organisations (Inserm, CNRS) and universities (UPMC PARIS 6)
– research programs (ANR, national research agency; PHRC: hospital programs for clinical research)
*European research initiatives (FP6, FP7, e-rare Eranet)
*Few private funds from lab companies
Q1 What conditions does your resource cover?
Neurodegenerative disease in general
Q2a What DNA collection does your resources hold?
Above 5000 donors
Q2b What cell lines does your resource hold?
Above 1000 distinct cell lines
Q2c What tissue (including post-mortem tissue) does your resource hold?
None
Q3 Are human tissues/samples/DNA from
Living donors:blood Living donors: blood derivatives Living donors: DNA Living donors: other, please specify below
Q4 Are tissues/samples/DNA from
Healthy individuals/control donors Patients
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Routinely collected as medical records In a specific study-associated dataset
Q6 In what form are samples supplied?
Primary Samples: Stabilised samples (frozen or fixed) Secondary samples: plasma Secondary samples: DNA Secondary samples: cell lines derived from primary samples Secondary samples: other types of cell lines Secondary samples: other (please specify)
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
No
Q8 What is the status of your tissue/sample/DNA collection?
Q9 What are the rules and procedures for access?
Apply to PI or co-ordinator at resource Access through collaboration with PI only International access Access to industry Access for pilot studies permitted Applicant needs to provide separate external ethics approval